A detailed history of Time Scale Financial, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Time Scale Financial, Inc. holds 608 shares of ABBV stock, worth $103,542. This represents 0.02% of its overall portfolio holdings.

Number of Shares
608
Previous 871 30.2%
Holding current value
$103,542
Previous $138,000 41.3%
% of portfolio
0.02%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $34,850 - $43,368
-263 Reduced 30.2%
608 $81,000
Q1 2023

Apr 21, 2023

BUY
$144.61 - $166.54 $30,368 - $34,973
210 Added 31.77%
871 $138,000
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $138 - $165
1 Added 0.15%
661 $106,000
Q3 2022

Oct 05, 2022

BUY
$134.21 - $153.93 $8,455 - $9,697
63 Added 10.55%
660 $89,000
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $28,624 - $36,391
-208 Reduced 25.84%
597 $91,000
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $8,578 - $10,643
-65 Reduced 7.47%
805 $131,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $752 - $951
7 Added 0.81%
870 $118,000
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $28,940 - $32,852
-272 Reduced 23.96%
863 $93,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $10,731 - $11,955
102 Added 9.87%
1,135 $128,000
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $716 - $788
7 Added 0.68%
1,033 $112,000
Q4 2020

Jan 28, 2021

SELL
$80.49 - $108.67 $7,324 - $9,888
-91 Reduced 8.15%
1,026 $110,000
Q3 2020

Oct 07, 2020

BUY
$85.91 - $100.83 $52,061 - $61,102
606 Added 118.59%
1,117 $97,000
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $2,274 - $3,043
31 Added 6.46%
511 $51,000
Q1 2020

Apr 09, 2020

SELL
$64.5 - $97.79 $3,289 - $4,987
-51 Reduced 9.6%
480 $36,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $629 - $757
-10 Reduced 1.85%
531 $40,000
Q2 2019

Jul 31, 2019

BUY
$65.7 - $83.98 $35,543 - $45,433
541 New
541 $39,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Time Scale Financial, Inc. Portfolio

Follow Time Scale Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Time Scale Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Time Scale Financial, Inc. with notifications on news.